Revelation Capital Management, LLC reported 1 positions worth $2.13M for the quarter ended Sep 30, 2026, down 98.1% on the prior quarter. It opened 0 new positions, added to 0, trimmed 0 and exited 1. Its largest holding is Artiva Biotherapeutics, Inc. at 100% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| OMDA Omada Health, Inc. | -4.86M | -100.0% | $106.63M | Exited |
No new positions this quarter.
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| OMDA Omada Health, Inc. | -4.86M | $106.63M | 97.35% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ARTV Artiva Biotherapeutics, Inc. | Healthcare | 299.3K | $2.13M | 100% | 0 | 0.0% | Unchanged | 0.61% |
Tip. Select a row to see that position’s full history at Revelation Capital Management.
As of its Q3 2026 13F filing, Revelation Capital Management, LLC’s five largest positions were Artiva Biotherapeutics, Inc. (ARTV) at 100.0% of the reported portfolio.
Revelation Capital Management, LLC reported a 13F portfolio worth $2.13M across 1 positions for Q3 2026. That is down 98.1% from the previous quarter.
Its largest sales by value were Omada Health, Inc. ($106.63M). It exited 1 positions entirely.
From the Form 13F-HR reports Revelation Capital Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.